Abstract Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome is a rare group of sterile, inXammatory osteoarticular disorders classically associated with skin lesions. It is occasionally associated with enteropathic disease such as ulcerative colitis. We present a 39-year-old patient with chronic ulcerative colitis who developed enteropathic SAPHO and responded well to pamidronate. We discuss the clinicopathological features with particular attention to bone pathology, and perform a literature review of this fascinating syndrome.
A 39-year-old woman was referred to the rheumatology department with a 6-month history of non-traumatic, relapsing and remitting, right clavicular pain and swelling in 2007. Her past medical history was signiWcant for a 20-year history of histologically conWrmed ulcerative pancolitis which required a subtotal colectomy in 2005. Three months prior to her colectomy, she had presented to the spinal surgery team with an acute episode of lumbar back pain which had last several weeks. Technetium scintigraphy was arranged to investigate the possibility of metastatic disease, showing increased uptake to L4 vertebral body. MRI spine excluded a fracture and revealed high intensity T2 lesions in the aVected vertebral body. Subsequent biopsy of L4 vertebral body was unremarkable except for irregular, thick trabeculae with osteoblasts and osteoclasts. As the symptoms had spontaneously resolved without recurrence 6 months later, she was subsequently discharged.
On examination, tenderness of the medial aspect of the right clavicle was elicited. Shoulder movements were normal. There were no dermatological Wndings. Chest X-ray revealed sclerosis of the aVected area, which had initially been normal on clavicular X-ray at presentation. Subsequent MRI revealed low-signal T1 lesion and hyperintense STIR signal aVecting the entire right clavicle and surrounding soft tissue (Fig. 1) , with sparing of the sternum, suggestive of a neoplastic or infective process. Her routine blood results revealed mildly elevated serum alkaline phosphatase (ALP) and C-reactive protein (CRP) concentrations at 75 /L and 17 mg/L, respectively. Serum white cell count, neutrophils, urea and electrolytes and remaining liver function parameters were all within normal limits. Corrected calcium was normal at 2.4 mmol/L. Blood cultures were negative. CT imaging (Fig. 2) to exclude Ewing's sarcoma demonstrated medullary sclerosis, irregular cortical erosion and periosteal reaction of the medial right clavicle, consistent with mild indolent osteomyelitis. Biopsy of the area revealed irregular bony trabeculae with increased osteoblastic and osteoclastic activity and associated Wbrosis.
In view of the clinical history of coexistent ulcerative colitis with radiological Wndings of hyperostosis and osteitis, and with the exclusion of an infective or malignant process, the diagnosis of enteropathic synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome was made. In hindsight, SAPHO may have aVected the L4 vertebra prior to colectomy, but was only recognised after presenting in her right clavicle 2 years after. Her symptoms abated with low-dose meloxicam. A trial of oral bisphosphonate failed to relieve symptoms, however, an initial infusion of intravenous bisphosphonate (60 mg pamidronate) eVectively drove the patient into remission. She now receives three monthly pamidronate infusions when required for frequent relapses.
Discussion
First coined by Chamot et al. [1] , the acronym SAPHO represents all Wve features of their osteoarticular-dermatological syndrome. Over the years, SAPHO has been controversially adapted to encompass a spectrum of disorders sharing clinical and histological features, with more than 50 previously independent entities included under this umbrella term [2] , such as chronic recurrent multifocal osteomyelitis (CRMO), anterior chest wall syndrome and sternocostoclavicular hyperostosis. Despite the acronym, osteitis and hyperostosis constitute the hallmarks of SAPHO syndrome. The diagnosis can be made in the absence of cutaneous signs, which if they present, usually occur within 2 years from the onset of bone symptoms, although the interval may be in excess of 20 years [3] . The currently accepted diagnostic criteria for SAPHO syndrome is based on fulWlling at least one of the following parameters originally determined by Kahn and Khan [2]:
1. Multifocal osteitis with or without skin manifestations 2. Sterile acute or chronic joint inXammation associated with either pustules from psoriasis (usually palmoplantar) or severe acne (conglobata or fulminans) 3. Sterile osteitis in the presence of any of the above skin manifestations.
SAPHO syndrome is rare with no accurate incidence data. It is of indeterminate aetiology, although some authors believe that an antigenic trigger, related to low grade Propionibacterium acnes infection, may be contributory [4] . Others regard SAPHO to be an additional member of the seronegative spondyloarthropathies [5, 6] , in view of common Wndings such as sacroiliitis and vertebral body involvement which occurs in about 50% of patients [2, 5] , the higher prevalence of the HLA-B27 antigen (in 33%) [1, 2, 6] , and the association with extra-articular manifestations such as inXammatory bowel disease [7] [8] [9] [10] , enthesopathies, uveitis and psoriasis [2, [6] [7] [8] . Chronic recurrent multifocal osteomyelitis, which is the commonest presentation of SAPHO syndrome, was found to aVect 49% of patients in one cohort consisting of 173 SAPHO patients [10] . CRMO is a clinicopathological diagnosis whereby sterile osteomyelitis (osteitis) is the key feature. The acronym is misleading. It is not necessarily chronic, recurrent nor multifocal in adults, although this is usually the case in children [10] . CRMO is usually chronic with a relapsing and remitting course, although a subacute course before permanent remission may be observed. It typically aVects multiple sites in children [1, 2] , although unifocal CRMO, especially when aVecting the clavicle, is a recognized entity in adults [10] . It is often described in children and young adults, and is rare in adults when the literal terminology is applied. Characteristically, the condition has a predilection for the anterior chest wall in 65-90%, with medial clavicle involvement being the clinical hallmark [11] . The vertebrae are the second most commonly aVected site (30%), followed by the diaphyses of long bones, mandible and iliac bones (in 10%) [11] . The number of aVected areas reduce with increasing age [10] . Technetium scintigraphy is useful for screening aVected sites. On X-ray and CT imaging, the aVected bone is often enlarged (hyperostosed) and sclerotic due to inXammation. MRI may reveal bone marrow oedema and synovitis. Histologically, a periosteal reaction from leukocyte inWltration, along with increased osteolytic and osteoblastic activity resembling Paget's disease may be observed [12, 13] . Absence of bacterial cells is obligatory. With clinical features that vary between children and adult CRMO [2, 13] , SAPHO syndrome is regarded by Kahn and Kahn [2] to be the adult version of CRMO.
The occurrence of SAPHO syndrome in a middle-aged patient with ulcerative colitis, as reported in our case, is very rare. In Germany, where the condition has been well recognized, the incidence of CRMO is estimated at 0.04% [10] , with the enteropathic variant reported to aVect 9% of CRMO patients [8] . However, enteropathic SAPHO are typically reported in children and young adults, with the majority of cases occurring in conjunction with Crohn's disease. Only 20-25% of enteropathic variants are associated with ulcerative colitis [8] . The overall picture is of CRMO, usually preceding gastrointestinal disease for as long as 5 years in children [7] . Skin lesions are present in 40% of cases [7] , with palmoplantar pustulosis being the commonest lesion [8] . Schilling and Marker-Hermann [8] proposed that the pathogenesis of enteropathic SAPHO may be similar to that of enteropathic spondyloarthropathies, and hypothesized that the disorder may be driven by a common antigen inappropriately activating T cells within lymphoid tissues of the skin-gut-bone axis. However, unlike spondyloarthropathies, most patients with enteropathic SAPHO are HLA-B27 negative. Furthermore, although the role of the synovium in autoimmune disease has been well explored, there is poor understanding why bone should be aVected. With regard to our patient, we believe that chronic inXammation within the gut from her 20-year history of colitis may have resulted in abnormal bowel permeability, thereby allowing the abnormal traYcking of lymphocytes from gut mucosa target other tissues. However, no in vitro pathological model exists of enteropathic SAPHO, and its mechanisms remain to be elucidated. Due to the rarity of the condition, the clinical presentation and course of enteropathic SAPHO in adults is also poorly understood.
Currently, no speciWc treatment exists for SAPHO syndrome. Due to the lack of patient numbers, there have been no randomized placebo-controlled trials. Traditionally, NSAIDs, sulfasalazine and corticosteroids have been tried with varying degrees of success. Azithromycin, which has been beneWcial for acne, has been reported to provide rapid osteoarticular relief in over 50% of patients [14] , and are used by some authorities as Wrst line [10] . InXiximab, which has conWrmed eYcacy in seronegative spondyloarthropathies, may have a role especially in SAPHO associated with Crohn's disease, although its evidence is conWned to case reports. Recently, nasal calcitonin has found favour in paediatric patients. However, intravenous pamidronate has now become the cornerstone of treatment for SAPHO syndrome given its safety proWle and eYcacy. In one series, it has induced complete remission in 60% and partial remission in 30% of patients [15] . Bisphosphonates were initially introduced based on their eYcacy in other conditions where bone becomes dysregulated, such as in Paget's disease, which shares histological similarities to CRMO. They act by inducing osteoclastic apoptosis and exert an anti-inXammatory eVect within bone by modulating cytokine concentrations [15] . Better understanding of SAPHO and its enteropathic variant is crucial for the treatment of the condition, which may carry a chronic course with prolonged morbidity.
Conclusion
We present a 39-year-old patient with ulcerative colitis with a rare diagnosis of enteropathic SAPHO syndrome predominantly aVecting the right clavicle, with good response to pamidronate therapy. Recognition of this condition is important, as the condition is often chronic, and treatment options are available. It can occur, but is often undiagnosed, in the absence of cutaneous manifestations. Knowledge of the condition may help to diVerentiate it from a malignant process and avoid repeated bone biopsies.
